Case Study: Top 10 Pharmaceutical Company assesses multiple sclerosis activity with Evidation wearable data

A Evidation Case Study

Preview of the Top 10 Pharmaceutical Company Case Study

Top 10 Pharmaceutical Company finds 1.5x more neuro MRIs with Evidation

A top 10 pharmaceutical company partnered with Evidation to address the challenge of using consumer wearable data to assess disease activity and progression in individuals with multiple sclerosis. The objective was to differentiate between MS patients and a control group by using mobility data from wearables as a proxy for disease state.

Evidation identified approximately 500 individuals with MS and 1,500 controls using medical claims data. The solution involved computing daily summaries of minute-level step and sleep data from wearables. This real-world data allowed researchers to identify notable differences between the groups and detect flare-up events. The results demonstrated that this passive data collection can identify individuals with MS, assess their quality of life, and document meaningful events. A key measurable impact was the finding that patients who switched disease-modifying therapies received neuro MRIs 1.5 times more often than single-DMT patients, suggesting potential suboptimal monitoring for some.


View this case study…

Evidation

11 Case Studies